首页 > 最新文献

Tzu Chi Medical Journal最新文献

英文 中文
Reply from the author for the letter to the editor concerning: Exploring mindfulness interventions for stress resilience in newly graduated nurses: A qualitative study. 作者回复编辑关于:探索正念干预对新毕业护士压力恢复力的影响:一项定性研究。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-04 eCollection Date: 2025-10-01 DOI: 10.4103/tcmj.tcmj_341_24
Shu-Chen Wang
{"title":"Reply from the author for the letter to the editor concerning: Exploring mindfulness interventions for stress resilience in newly graduated nurses: A qualitative study.","authors":"Shu-Chen Wang","doi":"10.4103/tcmj.tcmj_341_24","DOIUrl":"10.4103/tcmj.tcmj_341_24","url":null,"abstract":"","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 4","pages":"459"},"PeriodicalIF":1.6,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12574983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Narrative medicine in pediatric medical education and patient care: A scoping review. 叙事医学在儿科医学教育和病人护理:范围综述。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-04 eCollection Date: 2025-04-01 DOI: 10.4103/tcmj.tcmj_181_24
Ting-Chun Tseng, Pan-Yuan Kuo, Meei-Ju Lin, Shao-Yin Chu

Narrative medicine is an approach centered on patients' experiences and their illness stories. Its application in pediatric population warrants further research. This study aims to overview (1) the application of narrative medicine in pediatric medical education and (2) the implementation of narrative medicine in pediatric patient care. Searches were conducted in bibliographic databases (Cochrane Library, ClinicalTrials.gov, EBSCOhost, Embase, MedEdPORTAL, Ovid, PubMed, and Web of Science) without date or language restrictions. Researchers independently screened articles, charted data, and performed data synthesis. Educational intervention studies were evaluated with Kirkpatrick Scale, and Mixed Methods Appraisal Tool was used for methodological quality assessment of all studies. Forty-one articles met our criteria: 17 focused on the application of narrative medicine in pediatric medical education and 24 on its implementation in pediatric patient care. Educational interventions indicated general satisfaction, with reported improvements in empathy, reflection, patient understanding, and professional development. In patient care settings, narrative medicine provided a safe space for story sharing, enhancing emotional, relational, and social connections, and promoting patient- and family-centered care. This review highlights the translation of narrative medicine from educational interventions to clinical practice in pediatric settings. Although more robust research is required, existing evidence supports narrative medicine's potential to foster authentic engagement with patients and caregivers and enhance the quality of pediatric care across various conditions and developmental stages.

叙事医学是一种以病人的经历和他们的疾病故事为中心的方法。其在儿科人群中的应用值得进一步研究。本研究旨在概述(1)叙事医学在儿科医学教育中的应用(2)叙事医学在儿科患者护理中的实施。在书目数据库(Cochrane Library、ClinicalTrials.gov、EBSCOhost、Embase、MedEdPORTAL、Ovid、PubMed和Web of Science)中进行检索,没有日期和语言限制。研究人员独立筛选文章,绘制数据图表,并进行数据合成。采用Kirkpatrick量表对教育干预研究进行评价,采用混合方法评价工具对所有研究进行方法学质量评价。41篇文章符合我们的标准:17篇关注叙事医学在儿科医学教育中的应用,24篇关注叙事医学在儿科患者护理中的实施。教育干预显示了总体满意度,据报道在移情、反思、病人理解和专业发展方面有所改善。在患者护理环境中,叙事医学为故事分享提供了一个安全的空间,增强了情感、关系和社会联系,促进了以患者和家庭为中心的护理。这篇综述强调了叙事医学从教育干预到儿科临床实践的翻译。虽然还需要更有力的研究,但现有证据支持叙事医学在促进与患者和护理人员的真实接触以及提高不同疾病和发育阶段儿科护理质量方面的潜力。
{"title":"Narrative medicine in pediatric medical education and patient care: A scoping review.","authors":"Ting-Chun Tseng, Pan-Yuan Kuo, Meei-Ju Lin, Shao-Yin Chu","doi":"10.4103/tcmj.tcmj_181_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_181_24","url":null,"abstract":"<p><p>Narrative medicine is an approach centered on patients' experiences and their illness stories. Its application in pediatric population warrants further research. This study aims to overview (1) the application of narrative medicine in pediatric medical education and (2) the implementation of narrative medicine in pediatric patient care. Searches were conducted in bibliographic databases (Cochrane Library, ClinicalTrials.gov, EBSCOhost, Embase, MedEdPORTAL, Ovid, PubMed, and Web of Science) without date or language restrictions. Researchers independently screened articles, charted data, and performed data synthesis. Educational intervention studies were evaluated with Kirkpatrick Scale, and Mixed Methods Appraisal Tool was used for methodological quality assessment of all studies. Forty-one articles met our criteria: 17 focused on the application of narrative medicine in pediatric medical education and 24 on its implementation in pediatric patient care. Educational interventions indicated general satisfaction, with reported improvements in empathy, reflection, patient understanding, and professional development. In patient care settings, narrative medicine provided a safe space for story sharing, enhancing emotional, relational, and social connections, and promoting patient- and family-centered care. This review highlights the translation of narrative medicine from educational interventions to clinical practice in pediatric settings. Although more robust research is required, existing evidence supports narrative medicine's potential to foster authentic engagement with patients and caregivers and enhance the quality of pediatric care across various conditions and developmental stages.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 2","pages":"167-174"},"PeriodicalIF":1.4,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12048120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unmet needs of metabolic dysfunction - Associated "fatty or steatotic" liver disease. 未满足代谢功能障碍的需要-相关的“脂肪或脂肪变性”肝病。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-04 eCollection Date: 2025-04-01 DOI: 10.4103/tcmj.tcmj_232_24
Yu-Ming Cheng, Shao-Wen Wang, Ching Wang, Chia-Chi Wang

Nonalcoholic fatty liver disease (NAFLD), first named in 1980, is currently the most common chronic liver disease, imposing significant health, social, and economic burdens. However, it is defined as a diagnosis of exclusion, lacking a clear underlying cause in its diagnostic criteria. In 2020, metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed as a replacement for NAFLD, introducing additional criteria related to metabolic dysfunction. In 2023, metabolic dysfunction-associated steatotic liver disease (MASLD) was suggested to replace NAFLD, aiming to avoid the stigmatizing term "fatty" and incorporating cardiometabolic criteria for metabolic dysfunction. This divergence in nomenclature and diagnostic criteria between MAFLD and MASLD presents challenges to medical communication and progress. This review outlines the pros and cons of both terminologies, based on current research evidence, in the hope of fostering global consensus in the future.

非酒精性脂肪性肝病(NAFLD)于1980年首次被命名,是目前最常见的慢性肝病,造成了重大的健康、社会和经济负担。然而,它被定义为排除性诊断,在其诊断标准中缺乏明确的潜在原因。2020年,代谢功能障碍相关脂肪性肝病(MAFLD)被提出作为NAFLD的替代,引入了与代谢功能障碍相关的额外标准。2023年,代谢功能障碍相关脂肪变性肝病(MASLD)被建议取代NAFLD,旨在避免污名化术语“脂肪”,并纳入代谢功能障碍的心脏代谢标准。这种在命名和诊断标准上的分歧在mald和MASLD之间提出了医学交流和进步的挑战。本文根据目前的研究证据,概述了这两个术语的优缺点,希望在未来促进全球共识。
{"title":"Unmet needs of metabolic dysfunction - Associated \"fatty or steatotic\" liver disease.","authors":"Yu-Ming Cheng, Shao-Wen Wang, Ching Wang, Chia-Chi Wang","doi":"10.4103/tcmj.tcmj_232_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_232_24","url":null,"abstract":"<p><p>Nonalcoholic fatty liver disease (NAFLD), first named in 1980, is currently the most common chronic liver disease, imposing significant health, social, and economic burdens. However, it is defined as a diagnosis of exclusion, lacking a clear underlying cause in its diagnostic criteria. In 2020, metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed as a replacement for NAFLD, introducing additional criteria related to metabolic dysfunction. In 2023, metabolic dysfunction-associated steatotic liver disease (MASLD) was suggested to replace NAFLD, aiming to avoid the stigmatizing term \"fatty\" and incorporating cardiometabolic criteria for metabolic dysfunction. This divergence in nomenclature and diagnostic criteria between MAFLD and MASLD presents challenges to medical communication and progress. This review outlines the pros and cons of both terminologies, based on current research evidence, in the hope of fostering global consensus in the future.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 2","pages":"152-156"},"PeriodicalIF":1.4,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12048125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143990194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor concerning: Exploring mindfulness interventions for stress resilience in newly graduated nurses: A qualitative study. 致编辑关于:探索正念干预对新毕业护士压力恢复力的影响:一项定性研究。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-18 eCollection Date: 2025-10-01 DOI: 10.4103/tcmj.tcmj_283_24
Saurabh RamBihariLal Shrivastava
{"title":"Letter to the editor concerning: Exploring mindfulness interventions for stress resilience in newly graduated nurses: A qualitative study.","authors":"Saurabh RamBihariLal Shrivastava","doi":"10.4103/tcmj.tcmj_283_24","DOIUrl":"10.4103/tcmj.tcmj_283_24","url":null,"abstract":"","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 4","pages":"457-458"},"PeriodicalIF":1.6,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12574982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis. 探索高危人乳头瘤病毒感染的自然和获得性免疫机制,揭示宫颈癌的免疫逃逸:简要概述。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-03 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_134_24
Mohammed Mohsen Mohammed, Zaytoon Abdulrida Ighewish Al-Khafaji, Nadia Mudher Al-Hilli

The most common STD that triggers cervical cancer is the human papillomavirus. More than 20 types of human papillomavirus (HPV) can induce uterine cervical cancer. Almost all women acquire genital HPV infection soon after their first intercourse, with most of them clearing the virus within 3 years. An immune response is necessary to clear. The first responders to HPV infection are the innate immune system elements composed of macrophages, keratinocytes, natural killer cells, and natural killer T-lymphocytic (NKT) cells. Cytotoxic T lymphocytes (CTLs) comprise the second line of defense and kill HPV16-infected cells expressing various peptides derived from their transforming early viral oncoproteins, mainly E2•E6. Even though HPV can manage to trick away our immune systems, first of all, it is important to emphasize that HPV replication does not kill the host cells. It does not replicate viral antigens or cause inflammation. The HPV16 E6 and E7 genes suppress host cell type 1 interferons (IFNs), which are detectable after infection. The patient may have immunological tolerance; hence, there are no costimulatory signals from inflammatory cytokines like IFNs during antigen recognition. Evidence shows that HlA class I generations have been inhibited by HPV16 E5, which could protect this tumor cell from CTL attack. HPV16 E7 is responsible for initiating immunotolerance and increasing regulatory T cells (Treg) to repress immunological regression. Evasion from immune system protection plays a critical role in the outcome of persistent HPV infection and the development of cervical cancer. Vaccination against HPV16 and 18 during adolescence is the most effective method for preventing cervical cancer in women, considering the immunological processes involved.

最常见的引发子宫颈癌的性病是人乳头瘤病毒。20多种人乳头瘤病毒(HPV)可诱发子宫癌。几乎所有妇女在第一次性交后不久就会感染生殖器HPV,其中大多数人在3年内清除病毒。免疫反应是清除细菌的必要条件。对HPV感染的第一反应者是先天免疫系统元件,由巨噬细胞、角质形成细胞、自然杀伤细胞和自然杀伤t淋巴细胞(NKT)细胞组成。细胞毒性T淋巴细胞(ctl)构成第二道防线,杀死hpv16感染的细胞,这些细胞表达来自其转化的早期病毒癌蛋白的各种肽,主要是E2•E6。尽管HPV可以欺骗我们的免疫系统,但首先,重要的是要强调HPV的复制不会杀死宿主细胞。它不会复制病毒抗原,也不会引起炎症。HPV16 E6和E7基因抑制宿主细胞1型干扰素(ifn),感染后可检测到ifn。患者可能有免疫耐受;因此,在抗原识别过程中,炎性细胞因子如ifn不存在共刺激信号。有证据表明,hpv16e5能够抑制HlA I类代,从而保护肿瘤细胞免受CTL的攻击。hpv16e7负责启动免疫耐受和增加调节性T细胞(Treg)来抑制免疫消退。逃避免疫系统保护在持续HPV感染和宫颈癌发展的结果中起着关键作用。考虑到所涉及的免疫过程,在青春期接种HPV16和18疫苗是预防妇女宫颈癌的最有效方法。
{"title":"An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis.","authors":"Mohammed Mohsen Mohammed, Zaytoon Abdulrida Ighewish Al-Khafaji, Nadia Mudher Al-Hilli","doi":"10.4103/tcmj.tcmj_134_24","DOIUrl":"10.4103/tcmj.tcmj_134_24","url":null,"abstract":"<p><p>The most common STD that triggers cervical cancer is the human papillomavirus. More than 20 types of human papillomavirus (HPV) can induce uterine cervical cancer. Almost all women acquire genital HPV infection soon after their first intercourse, with most of them clearing the virus within 3 years. An immune response is necessary to clear. The first responders to HPV infection are the innate immune system elements composed of macrophages, keratinocytes, natural killer cells, and natural killer T-lymphocytic (NKT) cells. Cytotoxic T lymphocytes (CTLs) comprise the second line of defense and kill HPV16-infected cells expressing various peptides derived from their transforming early viral oncoproteins, mainly E2•E6. Even though HPV can manage to trick away our immune systems, first of all, it is important to emphasize that HPV replication does not kill the host cells. It does not replicate viral antigens or cause inflammation. The HPV16 E6 and E7 genes suppress host cell type 1 interferons (IFNs), which are detectable after infection. The patient may have immunological tolerance; hence, there are no costimulatory signals from inflammatory cytokines like IFNs during antigen recognition. Evidence shows that HlA class I generations have been inhibited by HPV16 E5, which could protect this tumor cell from CTL attack. HPV16 E7 is responsible for initiating immunotolerance and increasing regulatory T cells (Treg) to repress immunological regression. Evasion from immune system protection plays a critical role in the outcome of persistent HPV infection and the development of cervical cancer. Vaccination against HPV16 and 18 during adolescence is the most effective method for preventing cervical cancer in women, considering the immunological processes involved.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"28-41"},"PeriodicalIF":1.4,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of prehospital stroke assessment scales for acute ischemic stroke with large vessel occlusion within six hours of onset: A single-center study in Eastern Taiwan. 急性缺血性脑卒中伴大血管闭塞6小时院前卒中评估量表比较:台湾东部单中心研究。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-27 eCollection Date: 2025-07-01 DOI: 10.4103/tcmj.tcmj_191_24
Phyo-Wai Thu, Yu-Ping Yu, Jen-Hung Wang, Chooi-Lan Liew

Objectives: In Taiwan, acute ischemic stroke (AIS) with large vessel occlusion (LVO) remains a significant health concern. Reperfusion therapy is more effective if the patient arrives at the medical center within the early time window, emphasizing the importance of prehospital stroke assessment to identify LVO and rapid transfer. This study focused on Eastern Taiwan, where the Hualien Tzu Chi Hospital is the sole comprehensive stroke center. We compared different prehospital stroke assessment scales in identifying LVO.

Materials and methods: We reviewed 598 patients with acute stroke admitted to our hospital's emergency department between April 1, 2021, and March 31, 2022. Of these, 110 AIS cases presenting within 6 h of symptom onset were retrospectively analyzed using the medical records and National Institute of Health Stroke Scale (NIHSS) scores to evaluate the efficacies of prehospital stroke scales, including our institution's Tzu Chi Stroke Severity Scale and its modified version. LVO was defined as occlusion of the anterior cerebral artery, middle cerebral artery, and its main branches, intracranial carotid arteries, and vertebrobasilar arteries.

Results: Among 110 patients, 39.1% had LVO, which showed a higher mortality rate and prevalence of atrial fibrillation. LVO had higher NIHSS scores and longer hospital stays. The Vision Aphasia Neglect (VAN) Scale and Modified Tzu Chi Stroke Severity Scale showed the highest sensitivity, with the latter also exhibiting the highest sensitivity for posterior circulation LVO.

Conclusion: The VAN and the modified Tzu Chi Stroke Severity Scale offer comparable sensitivity for detecting LVO in the prehospital setting. Our study supports the adoption of the modified Tzu Chi scale in the regional emergency medical service transfer algorithm for LVO detection for timely intervention.

目的:在台湾,急性缺血性脑卒中(AIS)合并大血管闭塞(LVO)仍然是一个重要的健康问题。如果患者在较早的时间窗口内到达医疗中心,再灌注治疗更有效,强调院前卒中评估对识别LVO和快速转移的重要性。本研究以台湾东部为研究对象,花莲慈济医院是当地唯一的综合性脑卒中中心。我们比较了不同院前卒中评估量表在识别LVO方面的差异。材料和方法:我们回顾了2021年4月1日至2022年3月31日在我院急诊科收治的598例急性脑卒中患者。本研究选取110例在症状出现6小时内出现的AIS病例,采用病历资料及美国国立卫生研究院卒中量表(NIHSS)评分进行回顾性分析,评估院前卒中量表(包括本院慈济卒中严重程度量表及其修订版本)的疗效。LVO定义为大脑前动脉、大脑中动脉及其主要分支、颅内颈动脉、椎基底动脉闭塞。结果:110例患者中LVO发生率为39.1%,死亡率和房颤发生率均较高。LVO患者NIHSS评分较高,住院时间较长。视觉失语忽视(VAN)量表和改良慈济中风严重程度量表敏感度最高,改良慈济中风严重程度量表对后循环LVO敏感度也最高。结论:VAN与改良的慈济脑卒中严重程度量表在院前检测LVO具有相当的敏感性。本研究支持在区域紧急医疗服务转移算法中,采用修正慈济量表侦测LVO,以便及时介入。
{"title":"Comparison of prehospital stroke assessment scales for acute ischemic stroke with large vessel occlusion within six hours of onset: A single-center study in Eastern Taiwan.","authors":"Phyo-Wai Thu, Yu-Ping Yu, Jen-Hung Wang, Chooi-Lan Liew","doi":"10.4103/tcmj.tcmj_191_24","DOIUrl":"10.4103/tcmj.tcmj_191_24","url":null,"abstract":"<p><strong>Objectives: </strong>In Taiwan, acute ischemic stroke (AIS) with large vessel occlusion (LVO) remains a significant health concern. Reperfusion therapy is more effective if the patient arrives at the medical center within the early time window, emphasizing the importance of prehospital stroke assessment to identify LVO and rapid transfer. This study focused on Eastern Taiwan, where the Hualien Tzu Chi Hospital is the sole comprehensive stroke center. We compared different prehospital stroke assessment scales in identifying LVO.</p><p><strong>Materials and methods: </strong>We reviewed 598 patients with acute stroke admitted to our hospital's emergency department between April 1, 2021, and March 31, 2022. Of these, 110 AIS cases presenting within 6 h of symptom onset were retrospectively analyzed using the medical records and National Institute of Health Stroke Scale (NIHSS) scores to evaluate the efficacies of prehospital stroke scales, including our institution's Tzu Chi Stroke Severity Scale and its modified version. LVO was defined as occlusion of the anterior cerebral artery, middle cerebral artery, and its main branches, intracranial carotid arteries, and vertebrobasilar arteries.</p><p><strong>Results: </strong>Among 110 patients, 39.1% had LVO, which showed a higher mortality rate and prevalence of atrial fibrillation. LVO had higher NIHSS scores and longer hospital stays. The Vision Aphasia Neglect (VAN) Scale and Modified Tzu Chi Stroke Severity Scale showed the highest sensitivity, with the latter also exhibiting the highest sensitivity for posterior circulation LVO.</p><p><strong>Conclusion: </strong>The VAN and the modified Tzu Chi Stroke Severity Scale offer comparable sensitivity for detecting LVO in the prehospital setting. Our study supports the adoption of the modified Tzu Chi scale in the regional emergency medical service transfer algorithm for LVO detection for timely intervention.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 3","pages":"311-320"},"PeriodicalIF":1.6,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple, economical, and high-yield method for polyethylene glycol-based extraction of follicular and serum-derived extracellular vesicles. 一种简单、经济、高产的聚乙二醇提取卵泡和血清来源的细胞外囊泡的方法。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-25 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_160_24
Aye Aye Khine, Pao-Chu Chen, Ying-Hsi Chen, Sung-Chao Chu, Yu-Shuan Chen, Hsuan-Shun Huang, Tang-Yuan Chu

Objectives: The optimization of polyethylene glycol (PEG)-based extracellular vesicles (EVs) extraction from human follicular fluid (FF) and serum was investigated, and their functional analysis was confirmed. The PEG-based EV results were compared to the ExoQuick (ExoQ)-based EV.

Materials and methods: FF-EVs and serum-EVs were extracted by using different concentrations of PEG (8000). Nanoparticle tracking analysis was used to count the particles, and electron microscopy of EVs was performed for visualization. Exosomes were confirmed by the western blot analysis with exosome-specific markers. RNA and microRNA were extracted from exosomes and quantitative polymerase chain reaction analysis was performed. Fallopian tube epithelial (FTE) cells were used for the EV uptake experiment and an anchorage-independent growth test to confirm that extracted EVs harbor transformation activity.

Results: The PEG 8% enriched method produced the highest yield and the lowest carry-over protein. Salt containing PEG 8% produced a higher yield than nonsalted PEG 8%. Overnight enrichment increased four times and 18 times for PEG 8% and ExoQ-based EV extraction from FF. For serum EV, the same overnight enrichment moderately increased yield for both PEG 8% and ExoQ methods. Less carry-over protein resulted in more EV-promoted transformation activity.

Conclusion: This study overcomes the time-consuming, expensive, laborious, and complicated machine-dependent EV extraction methods. The study highlights that longer incubation time is needed for EV extraction from FF. PEG 8000-based EV extraction provided a higher yield and less carry-over protein than ExoQ-based EV extraction.

目的:研究聚乙二醇(PEG)基细胞外囊泡(ev)从人卵泡液(FF)和血清中提取的最佳工艺条件,并对其进行功能分析。将基于peg的EV结果与基于ExoQuick (ExoQ)的EV结果进行比较。材料和方法:采用不同浓度PEG(8000)提取ff - ev和血清ev。采用纳米颗粒跟踪分析对颗粒进行计数,并对电动汽车进行电子显微镜观察。外泌体通过外泌体特异性标记物的western blot分析证实。从外泌体中提取RNA和microRNA,进行定量聚合酶链反应分析。利用输卵管上皮细胞(FTE)进行EV摄取实验和非锚定生长实验,以证实提取的EV具有转化活性。结果:PEG 8%富集法产率最高,携带蛋白最低。含PEG 8%的盐比不含PEG 8%的盐产量高。从FF中提取PEG 8%和exoq为基础的EV,隔夜富集量分别增加了4倍和18倍。对于血清EV,同样的隔夜富集可适度提高PEG法和ExoQ法的产量(8%)。携带蛋白的减少导致ev促进的转化活性增加。结论:本研究克服了耗时、昂贵、费力、复杂的机器依赖EV提取方法。研究表明,从FF中提取EV需要较长的孵育时间。与exoq提取相比,PEG 8000提取的EV提取率更高,携带的蛋白质更少。
{"title":"A simple, economical, and high-yield method for polyethylene glycol-based extraction of follicular and serum-derived extracellular vesicles.","authors":"Aye Aye Khine, Pao-Chu Chen, Ying-Hsi Chen, Sung-Chao Chu, Yu-Shuan Chen, Hsuan-Shun Huang, Tang-Yuan Chu","doi":"10.4103/tcmj.tcmj_160_24","DOIUrl":"10.4103/tcmj.tcmj_160_24","url":null,"abstract":"<p><strong>Objectives: </strong>The optimization of polyethylene glycol (PEG)-based extracellular vesicles (EVs) extraction from human follicular fluid (FF) and serum was investigated, and their functional analysis was confirmed. The PEG-based EV results were compared to the ExoQuick (ExoQ)-based EV.</p><p><strong>Materials and methods: </strong>FF-EVs and serum-EVs were extracted by using different concentrations of PEG (8000). Nanoparticle tracking analysis was used to count the particles, and electron microscopy of EVs was performed for visualization. Exosomes were confirmed by the western blot analysis with exosome-specific markers. RNA and microRNA were extracted from exosomes and quantitative polymerase chain reaction analysis was performed. Fallopian tube epithelial (FTE) cells were used for the EV uptake experiment and an anchorage-independent growth test to confirm that extracted EVs harbor transformation activity.</p><p><strong>Results: </strong>The PEG 8% enriched method produced the highest yield and the lowest carry-over protein. Salt containing PEG 8% produced a higher yield than nonsalted PEG 8%. Overnight enrichment increased four times and 18 times for PEG 8% and ExoQ-based EV extraction from FF. For serum EV, the same overnight enrichment moderately increased yield for both PEG 8% and ExoQ methods. Less carry-over protein resulted in more EV-promoted transformation activity.</p><p><strong>Conclusion: </strong>This study overcomes the time-consuming, expensive, laborious, and complicated machine-dependent EV extraction methods. The study highlights that longer incubation time is needed for EV extraction from FF. PEG 8000-based EV extraction provided a higher yield and less carry-over protein than ExoQ-based EV extraction.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"49-57"},"PeriodicalIF":1.4,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis/bladder pain syndrome. 反复膀胱内注射富血小板血浆治疗间质性膀胱炎/膀胱疼痛综合征安全有效。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-16 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_166_24
Wan-Ru Yu, Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo

Objectives: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a challenging chronic inflammatory condition affecting the urinary bladder, with limited treatment options. This study aims to assess the clinical efficacy of repeated intravesical platelet-rich plasma (PRP) injections for promoting urothelial regeneration and reducing inflammation in patients with IC/BPS and investigate its correlation with subjective and objective treatment-related outcomes.

Materials and methods: Four monthly intravesical PRP injections were given to 98 patients with non-Hunner-type IC/BPS. Treatment outcomes were assessed using a global response assessment (GRA) score 3 months posttreatment. In addition, clinical symptom scores, pain severity, voiding diary data, uroflowmetry parameters, and GRA scores were compared before and after treatment and between different treatment outcome groups (satisfactory: GRA≥2 unsatisfactory: GRA<2). Baseline urine biomarkers were analyzed to identify potential treatment outcome predictors.

Results: After four PRP injections, 54 (55.1%) patients reported satisfactory outcomes. Lower urinary tract symptoms, bladder pain, urinary frequency, anxiety, and flow rate significantly improved from baseline (P < 0.05) in all patients, regardless of the treatment outcome. All patients experienced improved treatment outcomes and increased maximum bladder capacity with successive PRP treatments, and no major complications were reported. Urine biomarkers indicated elevated inflammation and oxidative stress biomarkers in patients with IC/BPS compared to controls.

Conclusion: Repeated PRP injections are safe and effective for reducing symptoms and bladder pain and improving bladder capacity in a majority of IC/BPS patients, with better outcomes observed in patients with a mild form of bladder inflammation. These results support PRP as a promising novel bladder therapy for IC/BPS.

目的:间质性膀胱炎/膀胱疼痛综合征(IC/BPS)是一种影响膀胱的具有挑战性的慢性炎症性疾病,治疗方案有限。本研究旨在评估反复膀胱内富血小板血浆(PRP)注射促进IC/BPS患者尿路上皮再生和减轻炎症的临床疗效,并探讨其与主客观治疗相关结果的相关性。材料与方法:对98例非hunner型IC/BPS患者每月进行4次膀胱内PRP注射。治疗后3个月采用总体反应评估(GRA)评分评估治疗结果。此外,比较治疗前后及不同治疗结果组之间的临床症状评分、疼痛严重程度、排尿日记数据、尿流仪参数和GRA评分(满意:GRA≥2不满意:GRA)结果:4次PRP注射后,54例(55.1%)患者报告满意结果。无论治疗结果如何,所有患者的下尿路症状、膀胱疼痛、尿频、焦虑和尿流率均较基线显著改善(P < 0.05)。所有患者经连续PRP治疗后治疗效果均有所改善,最大膀胱容量增加,无重大并发症报道。尿液生物标志物表明,与对照组相比,IC/BPS患者的炎症和氧化应激生物标志物升高。结论:在大多数IC/BPS患者中,重复PRP注射对于减轻症状和膀胱疼痛以及改善膀胱容量是安全有效的,在轻度膀胱炎症患者中观察到更好的结果。这些结果支持PRP作为一种有希望的新型膀胱治疗IC/BPS。
{"title":"Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis/bladder pain syndrome.","authors":"Wan-Ru Yu, Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo","doi":"10.4103/tcmj.tcmj_166_24","DOIUrl":"10.4103/tcmj.tcmj_166_24","url":null,"abstract":"<p><strong>Objectives: </strong>Interstitial cystitis/bladder pain syndrome (IC/BPS) is a challenging chronic inflammatory condition affecting the urinary bladder, with limited treatment options. This study aims to assess the clinical efficacy of repeated intravesical platelet-rich plasma (PRP) injections for promoting urothelial regeneration and reducing inflammation in patients with IC/BPS and investigate its correlation with subjective and objective treatment-related outcomes.</p><p><strong>Materials and methods: </strong>Four monthly intravesical PRP injections were given to 98 patients with non-Hunner-type IC/BPS. Treatment outcomes were assessed using a global response assessment (GRA) score 3 months posttreatment. In addition, clinical symptom scores, pain severity, voiding diary data, uroflowmetry parameters, and GRA scores were compared before and after treatment and between different treatment outcome groups (satisfactory: GRA≥2 unsatisfactory: GRA<2). Baseline urine biomarkers were analyzed to identify potential treatment outcome predictors.</p><p><strong>Results: </strong>After four PRP injections, 54 (55.1%) patients reported satisfactory outcomes. Lower urinary tract symptoms, bladder pain, urinary frequency, anxiety, and flow rate significantly improved from baseline (<i>P</i> < 0.05) in all patients, regardless of the treatment outcome. All patients experienced improved treatment outcomes and increased maximum bladder capacity with successive PRP treatments, and no major complications were reported. Urine biomarkers indicated elevated inflammation and oxidative stress biomarkers in patients with IC/BPS compared to controls.</p><p><strong>Conclusion: </strong>Repeated PRP injections are safe and effective for reducing symptoms and bladder pain and improving bladder capacity in a majority of IC/BPS patients, with better outcomes observed in patients with a mild form of bladder inflammation. These results support PRP as a promising novel bladder therapy for IC/BPS.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"72-79"},"PeriodicalIF":1.4,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of simultaneous treatment with intradetrusor onabotulinumtoxinA injections during transurethral prostate surgery for men with bladder outlet obstruction and overactive bladder. 经尿道前列腺手术期间肌内注射肉毒杆菌毒素治疗膀胱出口梗阻和膀胱过度活动的疗效综述。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-09 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_180_24
Chun-Kai Hsu, Wan-Ling Young, Shu-Yu Wu

Bladder outlet obstruction (BOO) is common in males with benign prostate enlargement (BPE) and often presents with different lower urinary tract symptoms. Overactive bladder (OAB) has been reported to be related to BOO, although it can also be idiopathic. The storage symptoms of BOO are often similar to those of OAB. The etiology and pathophysiology of both BPE and OAB are multifactorial with metabolic syndrome known as one of the factors. As of today, transurethral prostate surgery remains the gold standard for treating BOO associated with BPE. Intradetrusor onabotulinumtoxinA (BoNT-A) injections have been shown to be effective in treating OAB. However, they are usually administered after transurethral prostate surgery. In view of the strong therapeutic effects of both surgery and injections, the feasibility of combining them in one setting to increase patient comfort, convenience, and possibly results while decreasing costs is appealing to physicians. However, patient safety and possible complications have to be considered. In this article, we review available studies of concurrent intradetrusor BoNT-A injections during transurethral prostate surgery. Although there is no definitive evidence supporting the concurrent use of intradetrusor BoNT-A during transurethral prostate surgery, there are no reports of increased complications too. Further large-scale randomized controlled trials would be necessary to validate the feasibility of combining the treatments in one setting and observe for possible complications.

膀胱出口梗阻(BOO)常见于男性良性前列腺肥大(BPE),常表现为不同的下尿路症状。膀胱过动症(OAB)有报道与BOO有关,尽管它也可能是特发性的。BOO的储存症状通常与OAB相似。BPE和OAB的病因和病理生理是多因素的,代谢综合征是其中一个因素。时至今日,经尿道前列腺手术仍然是治疗伴BPE的BOO的金标准。肌内注射肉毒杆菌毒素(BoNT-A)已被证明对治疗OAB有效。然而,它们通常在经尿道前列腺手术后使用。鉴于手术和注射都具有很强的治疗效果,在降低成本的同时,将它们结合在一起以增加患者的舒适度、便利性和可能的效果的可行性对医生很有吸引力。然而,必须考虑患者的安全和可能的并发症。在本文中,我们回顾了经尿道前列腺手术中肌内同时注射BoNT-A的现有研究。虽然没有明确的证据支持在经尿道前列腺手术中同时使用肌内BoNT-A,但也没有增加并发症的报道。需要进一步的大规模随机对照试验来验证在一种情况下联合治疗的可行性,并观察可能的并发症。
{"title":"Review of simultaneous treatment with intradetrusor onabotulinumtoxinA injections during transurethral prostate surgery for men with bladder outlet obstruction and overactive bladder.","authors":"Chun-Kai Hsu, Wan-Ling Young, Shu-Yu Wu","doi":"10.4103/tcmj.tcmj_180_24","DOIUrl":"10.4103/tcmj.tcmj_180_24","url":null,"abstract":"<p><p>Bladder outlet obstruction (BOO) is common in males with benign prostate enlargement (BPE) and often presents with different lower urinary tract symptoms. Overactive bladder (OAB) has been reported to be related to BOO, although it can also be idiopathic. The storage symptoms of BOO are often similar to those of OAB. The etiology and pathophysiology of both BPE and OAB are multifactorial with metabolic syndrome known as one of the factors. As of today, transurethral prostate surgery remains the gold standard for treating BOO associated with BPE. Intradetrusor onabotulinumtoxinA (BoNT-A) injections have been shown to be effective in treating OAB. However, they are usually administered after transurethral prostate surgery. In view of the strong therapeutic effects of both surgery and injections, the feasibility of combining them in one setting to increase patient comfort, convenience, and possibly results while decreasing costs is appealing to physicians. However, patient safety and possible complications have to be considered. In this article, we review available studies of concurrent intradetrusor BoNT-A injections during transurethral prostate surgery. Although there is no definitive evidence supporting the concurrent use of intradetrusor BoNT-A during transurethral prostate surgery, there are no reports of increased complications too. Further large-scale randomized controlled trials would be necessary to validate the feasibility of combining the treatments in one setting and observe for possible complications.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"42-48"},"PeriodicalIF":1.4,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceived stress and coping strategies among undergraduate nursing students in the psychiatric practicum during the COVID-19 pandemic: A cross-sectional quantitative study. 2019冠状病毒病大流行期间精神科本科护生压力感知及应对策略的横断面定量研究
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-09 eCollection Date: 2025-04-01 DOI: 10.4103/tcmj.tcmj_132_24
Shiou-Fang Lu, Shu-Wan Chiang, Ya-Chuan Hsu

Objectives: This study aimed to explore perceived stress and coping strategies among undergraduate nursing students in the psychiatric practicum during the pandemic.

Materials and methods: A cross-sectional quantitative design was employed in this study. Data were collected through self-administered questionnaires consisting of demographic variables, the Perceived Stress Scale (PSS), and the Coping Behavior Inventory (CBI).

Results: Of the 73 participants, 82.2% were women. The mean age was 21.25 ± 0.69 years. The overall mean score of PSS was 1.45 ± 0.48, and that of CBI was 1.93 ± 0.31. The major sources of perceived stress were taking care of patients (1.72 ± 0.54) and assignments and workload (1.72 ± 0.75). The major coping strategies to deal with stress were problem-solving (2.66 ± 0.52) and staying optimistic (2.43 ± 0.73). Pearson's correlation analyses revealed that participants who utilized the avoidance strategy (r = 0.416) reported high-stress levels, whereas participants who utilized problem-solving (r = -0.306) and staying optimistic (r = -0.527) reported low-stress levels.

Conclusion: The nursing students perceived moderate stress mainly from taking care of patients as well as assignments and workload. Problem-solving and staying optimistic were the most frequently used coping strategies. Compared with findings from other studies, our data suggested that the impact of the COVID-19 pandemic on perceived stress was not apparent possibly due to well-established approaches and education for infection prevention and control in our hospitals and schools. Our findings may provide valuable information to maximize students' learning opportunities.

目的:本研究旨在探讨大流行期间精神科本科护生的压力感知及应对策略。材料与方法:本研究采用横断面定量设计。数据通过人口统计学变量、感知压力量表(PSS)和应对行为量表(CBI)组成的自填问卷收集。结果:73名参与者中,82.2%为女性。平均年龄21.25±0.69岁。PSS评分为1.45±0.48分,CBI评分为1.93±0.31分。感知压力的主要来源是照顾病人(1.72±0.54)和作业和工作量(1.72±0.75)。主要的应激应对策略为解决问题(2.66±0.52)和保持乐观(2.43±0.73)。皮尔逊相关分析显示,使用回避策略的参与者(r = 0.416)报告了高压力水平,而使用解决问题策略(r = -0.306)和保持乐观(r = -0.527)的参与者报告了低压力水平。结论:护生感受到的压力主要来自于照顾病人、工作任务和工作量。解决问题和保持乐观是最常用的应对策略。与其他研究结果相比,我们的数据表明,COVID-19大流行对感知压力的影响并不明显,这可能是由于我们的医院和学校建立了完善的感染预防和控制方法和教育。我们的研究结果可能提供有价值的信息,以最大限度地提高学生的学习机会。
{"title":"Perceived stress and coping strategies among undergraduate nursing students in the psychiatric practicum during the COVID-19 pandemic: A cross-sectional quantitative study.","authors":"Shiou-Fang Lu, Shu-Wan Chiang, Ya-Chuan Hsu","doi":"10.4103/tcmj.tcmj_132_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_132_24","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to explore perceived stress and coping strategies among undergraduate nursing students in the psychiatric practicum during the pandemic.</p><p><strong>Materials and methods: </strong>A cross-sectional quantitative design was employed in this study. Data were collected through self-administered questionnaires consisting of demographic variables, the Perceived Stress Scale (PSS), and the Coping Behavior Inventory (CBI).</p><p><strong>Results: </strong>Of the 73 participants, 82.2% were women. The mean age was 21.25 ± 0.69 years. The overall mean score of PSS was 1.45 ± 0.48, and that of CBI was 1.93 ± 0.31. The major sources of perceived stress were taking care of patients (1.72 ± 0.54) and assignments and workload (1.72 ± 0.75). The major coping strategies to deal with stress were problem-solving (2.66 ± 0.52) and staying optimistic (2.43 ± 0.73). Pearson's correlation analyses revealed that participants who utilized the avoidance strategy (<i>r</i> = 0.416) reported high-stress levels, whereas participants who utilized problem-solving (<i>r</i> = -0.306) and staying optimistic (<i>r</i> = -0.527) reported low-stress levels.</p><p><strong>Conclusion: </strong>The nursing students perceived moderate stress mainly from taking care of patients as well as assignments and workload. Problem-solving and staying optimistic were the most frequently used coping strategies. Compared with findings from other studies, our data suggested that the impact of the COVID-19 pandemic on perceived stress was not apparent possibly due to well-established approaches and education for infection prevention and control in our hospitals and schools. Our findings may provide valuable information to maximize students' learning opportunities.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 2","pages":"216-222"},"PeriodicalIF":1.4,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12048118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143990634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tzu Chi Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1